LLEli Lilly LLY · NYSE
$1,257.11 +0.44% (+$5.50)
- Market cap
- $1.18T
- Enterprise value
- $1.22T
- P/E
- 44.1x
- Forward P/E
- 37.4x
- PEG
- 0.6x
- P/S
- 14.8x
- P/FCF
- 58.8x
- EV/EBITDA
- 34.8x
- ROIC
- 27.4%
- Bruto marža
- 84.0%
- Neto marža
- 33.5%
- Dividend yield
- 0.53%
- Payout ratio
- 23.6%
- Neto dolg/EBITDA
- 1.3x
- Beta
- 0.45
- Free float
- 90.1%
O podjetju
Eli Lilly and Company (LLY) is an American pharmaceutical company with a long history and significant influence in the global pharmaceutical market. The company specializes in research, development, and manufacturing of medicinal products in various therapeutic areas, including diabetology, oncology, neurology, and others. Eli Lilly offers a wide range of pharmaceutical products and treatment approaches that help improve the health and quality of life of patients worldwide. The company invests in innovation and research to bring new drugs and treatment methods that could potentially change the way diseases are treated. Eli Lilly and Company is a respected name in the pharmaceutical industry and has a strong foundation for further growth and development. Investing in Eli Lilly and Company (LLY) shares may represent an attractive choice for investors seeking a reliable and innovative company in the healthcare sector.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
David A. Ricks
Employees
50,000
Headquarters
Indianapolis
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke